Biochemistry, Genetics and Molecular Biology
Adiponectin
19%
Adolescence
9%
Aerobic Metabolism
8%
Blood Plasma
25%
Body Composition
10%
Body Mass
8%
CD36
11%
Cell Function
14%
Cohort Study
16%
Electrospray Ionization
8%
Enzyme
8%
Fat Mass
8%
Gene Expression
6%
Glucose Blood Level
7%
Glucose Homeostasis
11%
Glucose Metabolism
18%
Glucose Test
8%
Glucose Tolerance Test
8%
Glucose Transport
10%
Glycogen Synthase
24%
HDL-Cholesterol
6%
High-Performance Liquid Chromatography
8%
Hyperglycemia
6%
Insulin Receptor
9%
Insulin Release
15%
Insulin Resistance
67%
Insulin Sensitivity
59%
Insulin Signaling
14%
Lean Body Weight
8%
Lipid
16%
Lipid Droplet
10%
Lipid Metabolism
8%
Messenger RNA
7%
Metabolic Pathway
6%
Mitochondrial Biogenesis
5%
Mitochondrial Disorder
9%
Mitochondrial Protein
6%
Mitochondrion
23%
Oxidative Phosphorylation
13%
Phosphopeptide
6%
Pioglitazone
10%
Prevalence
8%
Progeny
13%
Proteome
7%
Proteomics
14%
Receptor Gene
7%
Screening
7%
Skeletal Muscle
100%
Tandem Mass Spectrometry
9%
Triglyceride
7%
Medicine and Dentistry
Adiponectin
9%
Adipose Tissue
7%
Adolescence
5%
Aerobic Metabolism
6%
Androgen Therapy
14%
Beta Cell
14%
Birth Weight
6%
Body Mass Index
6%
Cardiometabolic Risk
6%
Cardiovascular Disease
15%
Cardiovascular Risk
10%
Cardiovascular System
6%
Cell Function
17%
Cohort Analysis
26%
Congestive Heart Failure
6%
Diabetes
23%
Diabetes Mellitus
14%
Diabetic Retinopathy
35%
Exercise
5%
Glucose Homeostasis
7%
Glucose Metabolism
7%
Glucose Uptake
8%
Glycogen Synthase
7%
Hazard Ratio
7%
Hemoglobin A1c
5%
High Density Lipoprotein Cholesterol
5%
Insulin Dependent Diabetes Mellitus
17%
Insulin Release
10%
Insulin Resistance
29%
Insulin Sensitivity
49%
Insulin Signaling
6%
Latent Autoimmune Diabetes in Adults
6%
Lean Body Weight
6%
Maturity Onset Diabetes of the Young
69%
Mitochondrion
7%
Oral Glucose Tolerance Test
8%
Patient with Type 2 Diabetes
21%
Placebo
9%
Polycystic Ovary Syndrome
9%
Prevalence
6%
Progeny
7%
Randomized Controlled Trial
8%
Screening
9%
Skeletal Muscle
34%
Substitution Therapy
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
5%
Cohort Study
7%
Congestive Heart Failure
5%
Diabetes Mellitus
11%
Diabetic Retinopathy
16%
Glycogen Synthase
8%
Hyperinsulinemia
7%
Insulin Dependent Diabetes Mellitus
13%
Insulin Resistance
14%
Metformin
9%
Non Insulin Dependent Diabetes Mellitus
56%
Normal Human
10%
Ovary Polycystic Disease
6%
Placebo
5%
Prevalence
5%
